Target
Bromodomain-containing protein 4 [1-477]
Ligand
BDBM445573
Substrate
n/a
Meas. Tech.
Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay
IC50
<5±n/a nM
Citation
 Quesnelle, CAHarikrishnan, LSHill, MD Tricyclic compounds as anticancer agents US Patent  US10683290 Publication Date 6/16/2020 
Target
Name:
Bromodomain-containing protein 4 [1-477]
Synonyms:
BRD4 | BRD4_HUMAN | Bromodomain-containing protein 4 (BRD4)(1-477) | HUNK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
52863.68
Organism:
Homo sapiens (Human)
Description:
O60885[1-477]
Residue:
475
Sequence:
MSAESGPGTRLRNLPVMGDGLETSQMSTTQAQAQPQPANAASTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETEIMIVQAKGRGRGRKETGTAKPGVSTVPNTTQASTPPQTQTPQPNPPPVQATPHPFPAVTPDLIVQTPVMTVVPPQPLQTPPPVPPQPQPPPAPAPQPVQSHPPIIAATPQPVKTKKGVKRKADTTTPTTIDPIHEPPSLPPEPKTTKLGQRRESSRPVKPPKKDVPDSQQHPAPEKSSKVSEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPDEPEEPVVAVSSPAVPP
  
Inhibitor
Name:
BDBM445573
Synonyms:
US10683290, Example 41
Type:
Small organic molecule
Emp. Form.:
C30H33FN6O3
Mol. Mass.:
544.6198
SMILES:
COc1cccnc1[C@@H](C1CCOCC1)n1c2cc(-c3c(C)nnn3C)c(F)cc2c2ncc(cc12)C(C)(C)O |r,wD:8.16,(2.66,4.53,;2.66,2.99,;4,2.22,;5.33,2.99,;6.66,2.22,;6.66,.68,;5.33,-.09,;4,.68,;2.66,-.09,;1.33,.68,;1.33,2.22,;-0,2.99,;-1.34,2.22,;-1.34,.68,;-0,-.09,;2.66,-1.63,;1.42,-2.54,;-.09,-2.22,;-1.12,-3.36,;-2.63,-3.04,;-3.77,-4.07,;-3.61,-5.6,;-5.1,-3.3,;-4.78,-1.8,;-3.25,-1.64,;-2.48,-.3,;-.64,-4.83,;-1.67,-5.97,;.86,-5.15,;1.89,-4,;3.43,-4,;4.46,-5.15,;5.97,-4.83,;6.45,-3.36,;5.42,-2.22,;3.91,-2.54,;7.95,-3.04,;9.46,-2.72,;8.27,-4.55,;7.63,-1.54,)|
Structure:
Search PDB for entries with ligand similarity: